XXEC Inc. Cuts Position in Mettler-Toledo International Inc. (NYSE:MTD)

XXEC Inc. reduced its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 2.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,746 shares of the medical instruments supplier’s stock after selling 60 shares during the quarter. Mettler-Toledo International makes up 2.6% of XXEC Inc.’s holdings, making the stock its 17th largest position. XXEC Inc.’s holdings in Mettler-Toledo International were worth $3,331,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in MTD. Allworth Financial LP grew its holdings in Mettler-Toledo International by 100.0% in the fourth quarter. Allworth Financial LP now owns 32 shares of the medical instruments supplier’s stock worth $39,000 after purchasing an additional 16 shares during the last quarter. Fulton Bank N.A. grew its stake in Mettler-Toledo International by 6.7% during the 4th quarter. Fulton Bank N.A. now owns 1,375 shares of the medical instruments supplier’s stock worth $1,668,000 after buying an additional 86 shares during the last quarter. International Assets Investment Management LLC grew its stake in Mettler-Toledo International by 109,458.1% during the 4th quarter. International Assets Investment Management LLC now owns 67,926 shares of the medical instruments supplier’s stock worth $82,392,000 after buying an additional 67,864 shares during the last quarter. Boston Trust Walden Corp increased its position in Mettler-Toledo International by 10.8% during the 4th quarter. Boston Trust Walden Corp now owns 35,015 shares of the medical instruments supplier’s stock valued at $42,472,000 after buying an additional 3,427 shares in the last quarter. Finally, Trust Point Inc. purchased a new stake in Mettler-Toledo International in the fourth quarter valued at about $224,000. Institutional investors own 95.07% of the company’s stock.

Insider Activity at Mettler-Toledo International

In other news, insider Christian Magloth sold 400 shares of the firm’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $1,278.73, for a total transaction of $511,492.00. Following the sale, the insider now directly owns 734 shares in the company, valued at approximately $938,587.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, insider Christian Magloth sold 400 shares of the stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $1,278.73, for a total transaction of $511,492.00. Following the transaction, the insider now owns 734 shares in the company, valued at approximately $938,587.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Elisha W. Finney sold 251 shares of the business’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $1,177.35, for a total transaction of $295,514.85. Following the completion of the sale, the director now directly owns 316 shares of the company’s stock, valued at approximately $372,042.60. The disclosure for this sale can be found here. Insiders sold a total of 951 shares of company stock worth $1,170,256 in the last three months. Company insiders own 1.94% of the company’s stock.

Mettler-Toledo International Price Performance

NYSE:MTD traded up $16.29 during mid-day trading on Friday, hitting $1,300.84. The company’s stock had a trading volume of 90,855 shares, compared to its average volume of 125,151. Mettler-Toledo International Inc. has a 1 year low of $928.49 and a 1 year high of $1,615.97. The stock has a market cap of $27.82 billion, a price-to-earnings ratio of 36.25, a PEG ratio of 3.55 and a beta of 1.15. The business’s fifty day moving average is $1,260.35 and its two-hundred day moving average is $1,160.86.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Friday, February 9th. The medical instruments supplier reported $9.40 earnings per share for the quarter, missing the consensus estimate of $10.32 by ($0.92). Mettler-Toledo International had a net margin of 20.82% and a negative return on equity of 904.59%. The company had revenue of $934.90 million for the quarter, compared to analysts’ expectations of $959.45 million. During the same quarter in the prior year, the business posted $12.10 earnings per share. The firm’s revenue was down 11.6% compared to the same quarter last year. Analysts anticipate that Mettler-Toledo International Inc. will post 39.9 EPS for the current fiscal year.

Analysts Set New Price Targets

MTD has been the topic of several recent analyst reports. Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,300.00 and gave the company an “in-line” rating in a report on Thursday. StockNews.com upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a research note on Sunday, March 31st. Finally, Citigroup reiterated a “sell” rating and set a $975.00 price target (down previously from $1,050.00) on shares of Mettler-Toledo International in a research note on Monday, December 11th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Mettler-Toledo International presently has an average rating of “Hold” and a consensus target price of $1,233.25.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.